Literature DB >> 25694261

Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review.

Peter Steinmann1, Christopher M Stone, C Simone Sutherland, Marcel Tanner, Fabrizio Tediosi.   

Abstract

OBJECTIVES: To review current and emerging tools for Gambiense HAT control and elimination, and propose strategies that integrate these tools with epidemiological evidence.
METHODS: We reviewed the scientific literature to identify contemporary and emerging tools and strategies for controlling and eliminating Gambiense HAT. Through an iterative process involving key stakeholders, we then developed comprehensive scenarios leading to elimination, considering both established and new tools for diagnosis, case treatment and vector control.
RESULTS: Core components of all scenarios include detecting and treating cases with established or emerging techniques. Relatively more intensive scenarios incorporate vector control. New tools considered include tiny targets for tsetse fly control, use of rapid diagnostic tests and oral treatment with fexinidazole or oxaboroles. Scenarios consider the time when critical new tools are expected to become ready for deployment by national control programmes. Based on a review of the latest epidemiological data, we estimate the various interventions to cover 1,380,600 km(2) and 56,986,000 people.
CONCLUSIONS: A number of new tools will fill critical gaps in the current armamentarium for diagnosing and treating Gambiense HAT. Deploying these tools in endemic areas will facilitate the comprehensive and sustainable control of the disease considerably and contribute to the ultimate goal of elimination.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Gambiense HAT; TAH Gambiense; THA gambiense; control; contrôle; eliminación; elimination; escenarios; estrategias; human African trypanosomiasis; scenarios; scénarios; strategies; stratégies; tripanosomiasis Africana humana; trypanosomiase humaine africaine; élimination

Mesh:

Year:  2015        PMID: 25694261     DOI: 10.1111/tmi.12483

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  25 in total

1.  Ethical Considerations for Global Health Decision-Making: Justice-Enhanced Cost-Effectiveness Analysis of New Technologies for Trypanosoma brucei gambiense.

Authors:  Maria W Merritt; C Simone Sutherland; Fabrizio Tediosi
Journal:  Public Health Ethics       Date:  2018-07-18       Impact factor: 1.940

Review 2.  The animal trypanosomiases and their chemotherapy: a review.

Authors:  Federica Giordani; Liam J Morrison; Tim G Rowan; Harry P DE Koning; Michael P Barrett
Journal:  Parasitology       Date:  2016-10-10       Impact factor: 3.234

3.  Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo.

Authors:  Kat S Rock; Steve J Torr; Crispin Lumbala; Matt J Keeling
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

4.  The global burden of disease study 2013: What does it mean for the NTDs?

Authors:  Jennifer R Herricks; Peter J Hotez; Valentine Wanga; Luc E Coffeng; Juanita A Haagsma; María-Gloria Basáñez; Geoffrey Buckle; Christine M Budke; Hélène Carabin; Eric M Fèvre; Thomas Fürst; Yara A Halasa; Charles H King; Michele E Murdoch; Kapa D Ramaiah; Donald S Shepard; Wilma A Stolk; Eduardo A Undurraga; Jeffrey D Stanaway; Mohsen Naghavi; Christopher J L Murray
Journal:  PLoS Negl Trop Dis       Date:  2017-08-03

5.  The lysosomotropic drug LeuLeu-OMe induces lysosome disruption and autophagy-independent cell death in Trypanosoma brucei.

Authors:  Hazel X Koh; Htay M Aye; Kevin S W Tan; Cynthia Y He
Journal:  Microb Cell       Date:  2015-07-30

6.  PNT1 Is a C11 Cysteine Peptidase Essential for Replication of the Trypanosome Kinetoplast.

Authors:  Jaspreet S Grewal; Karen McLuskey; Debanu Das; Elmarie Myburgh; Jonathan Wilkes; Elaine Brown; Leandro Lemgruber; Matthew K Gould; Richard J Burchmore; Graham H Coombs; Achim Schnaufer; Jeremy C Mottram
Journal:  J Biol Chem       Date:  2016-03-03       Impact factor: 5.157

7.  Trypanosoma brucei gambiense Infections in Mice Lead to Tropism to the Reproductive Organs, and Horizontal and Vertical Transmission.

Authors:  Nicolas Biteau; Corinne Asencio; Julien Izotte; Benoit Rousseau; Muriel Fèvre; Davita Pillay; Théo Baltz
Journal:  PLoS Negl Trop Dis       Date:  2016-01-06

8.  Metabolomics Identifies Multiple Candidate Biomarkers to Diagnose and Stage Human African Trypanosomiasis.

Authors:  Isabel M Vincent; Rónán Daly; Bertrand Courtioux; Amy M Cattanach; Sylvain Biéler; Joseph M Ndung'u; Sylvie Bisser; Michael P Barrett
Journal:  PLoS Negl Trop Dis       Date:  2016-12-12

9.  Performance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo.

Authors:  Crispin Lumbala; Paul R Bessell; Pascal Lutumba; Sylvain Baloji; Sylvain Biéler; Joseph M Ndung'u
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

10.  Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo.

Authors:  Rian Snijders; Alain Fukinsia; Yves Claeys; Epco Hasker; Alain Mpanya; Erick Miaka; Filip Meheus; Marleen Boelaert
Journal:  Emerg Infect Dis       Date:  2021-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.